BRIGHT MINDS BIOSCIENCES INC. earnings per share and revenue

DRUG earnings per share for the last quarter are 0.01 CAD whereas the estimation was -0.02 CAD which accounts for 144.44% surprise. Company revenue for the same period amounts to 0.00 CAD despite the estimated figure of 0.00 CAD. Estimated earnings per share for the next quarter are -0.46 CAD, and revenue is expected to reach 0.00 CAD. Also watch annual changes over time to get a bigger picture of DRUG earnings per share and revenue dynamics.